Press releases (by year)
2011
Cardio3 BioSciences Establishes US Subsidiary in Rochester, MN
Belgian economic mission in the U.S. is a success for Cardio3 BioSciences Cardio3 BioSciences and ATMI, Inc.Sign a Letter of intent FR NL
Mission économique et commerciale présidée par SAR le Prince Philippe aux Etats-Unis NL
Cardio3 BioSciences Presents C-Cure® Phase II Clinical Trial Results at the EuroPCR Meeting
Cardio3 BioSciences Announces International C-Cure® Phase II Clinical Trial at the 60th Annual American College of Cardiology Meeting FR NL
Cardio3 BioSciences Announces its new Board Members FR NL
2010
Cardio3 BioSciences Announces Significant Progress in its Programme for the Treatment of Acute Myocardial Infarction FR NL
Cardio3 BioSciences Announces Positive Outcome of the C-Cure Phase II Clinical Trial in Heart Failure Patients FR NL
Cardio3 BioSciences Publishes the Science Basis for C-Cure® in JACC FR NL
Cardio3 BioSciences Reports Positive Three-Month Data from its Clinical Trial of C-Cure® in Heart Failure FR NL
Cardio3 BioSciences Announces Promising Pre‐Clinical Data for Proprietary C‐Cath® Catheter FR NL
2009
Cardio3 BioSciences at ESC Barcelona
Cardio3 BioSciences To Present At Forthcoming BioEquity Europe 2009 Meeting
Cardio3 BioSciences at EuroPCR Barcelona
Cardio3 BioSciences Treats Its First Patient with C-Cure®,
a Second-Generation Stem Cell Derived Therapy for Heart Failure FR NL
Cardio3 BioSciences Raises €13.7 million in Series B Fundraising and Grant Funding
2008
